Om du har ytterligare frgor eller synpunkter kring hur vi hanterar dina personuppgifter kan du alltid kontakta oss, antingen via e-post p [email protected] eller via post till ngon av ovan nmnda postadresser
Christo Frangopoulos, MD, DipABLM, CPT from the Heal Nourish Grow advisory board specializes in lifestyle medicine
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
The current standard treatment CPAP has several disadvantages, including low compliance, reliance on hospital-based clinic devices, and potential weight gain, which is not conducive to long-term disease control [24]